Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;75(12):844-850.
doi: 10.1136/jclinpath-2021-207726. Epub 2021 Aug 16.

Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available

Affiliations

Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available

Cristiana Ercolani et al. J Clin Pathol. 2022 Dec.

Abstract

Aims: The minimally invasive procedures used in the diagnostic workup of patients with advanced non-small cell lung cancer (NSCLC) often provide poor yields of pathological material suitable for molecular analyses. Not infrequently, the DNA yield from small biopsies/cytological samples is insufficient for the assessment of genomic biomarkers that inform personalised therapies. The Idylla EGFR mutation test (IEMT) has been specifically designed to process formalin-fixed paraffin-embedded sections without requiring preliminary DNA extraction.This study aims to evaluate the diagnostic accuracy of IEMT when used to analyse archival histopathology material. More specifically, our objective was to establish whether or not different staining procedures could affect assay performance.

Methods: Twenty NSCLC samples were selected accordingly to EGFR mutational status. To mimic archived stained material, sections were subjected to H&E staining, fluorescent in situ hybridisation analyses or immunodetection by immunohistochemistry before being processed for IEMT.

Results: Parallel assessment of EGFR mutational status by IEMT on stained sections and next-generation sequencing on DNA yielded a concordant result in 50 out of 60 tests (83.3%). The discoloration of H&E of the archived sample was found to be the optimal procedure to highlight all the actionable alterations of EGFR.

Conclusions: IEMT can provide remarkable diagnostic accuracy for the assessment of EGFR mutational status also when the only source of pathological material available for molecular analyses is represented by H&E stained sections. Ad hoc supervision by a qualified molecular biologist is in any case recommended.

Keywords: DNA; diagnostic techniques and procedures; lung neoplasms; molecular biology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
(A) Case 5. Real-time PCR analyses of the EGFR-S768I point mutation on FISH sample (1) and DNA sample (2). Green curve indicates the amplification of the S768I-mutant allele, black curve indicates the amplification of a conserved region of the EGFR gene and is used to assess the total amount of DNA sample. (B) Case 16. Real-time PCR analyses of the EGFR-L858R point mutation on FISH sample (1) and DNA sample (2). Blue curve indicates the amplification of the L858R-mutant allele, black curve indicates the amplification of a conserved region of the EGFR gene and is used to assess the total amount of DNA sample. (C) Case 15. Real-time PCR analysis of the EGFR-L747_P753>S point mutation on FFPE curls sample (1) and DNA sample (2). Pink curve indicates the amplification of the L747_P753>S-mutant allele, black curve indicates the amplification of a conserved region of the EGFR gene and is used to assess the total amount of DNA sample. (D) Case 18. Real-time PCR analysis of the EGFR-T790M point mutation on FFPE curls sample (1) and DNA sample (2). Yellow curve indicates the amplification of the T790M-mutant allele, black curve indicates the amplification of a conserved region of the EGFR gene and is used to assess the total amount of DNA sample. CQ, quality control; Cq, quantification cycle; FFPE, formalin-fixed paraffin-embedded; FISH, fluorescence in situ hybridisation.

References

    1. WHO . Cancer. Available: https://www.who.int/news-room/fact-sheets/detail/cancer [Accessed 12 May 2021].
    1. American Cancer Society . Cancer Facts & Figures, 2018. Available: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-... [Accessed 12 May 2021].
    1. Gandara DR, Lara PN, Mack P, et al. . Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-making. Clin Lung Cancer 2009;10:148–50. 10.3816/CLC.2009.n.020 - DOI - PubMed
    1. Sundar R, Chénard-Poirier M, Collins DC, et al. . Imprecision in the era of precision medicine in non-small cell lung cancer. Front Med 2017;4:39. 10.3389/fmed.2017.00039 - DOI - PMC - PubMed
    1. Lindeman NI, Cagle PT, Aisner DL, et al. . Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American pathologists, the International association for the study of lung cancer, and the association for molecular pathology. Arch Pathol Lab Med 2018;142:321–46. 10.5858/arpa.2017-0388-CP - DOI - PubMed

MeSH terms